⌘K

Login Start Free

Home/Filings/4/0001415889-25-023647

4//SEC Filing

Raykov Rosty 4

Accession 0001415889-25-023647

CIK 0001211583other

View on SEC.gov Company Profile

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 4:10 PM ET

Size

5.0 KB

Accession

0001415889-25-023647

Insider Transaction Report

Form 4

Period: 2025-09-04

FENNEC PHARMACEUTICALS INC.FENC

DirectorChief Executive Officer

Transactions

Sale
Common shares
2025-09-04$8.92/sh−10,000$89,200→ 51,086 total

Footnotes (1)

[F1]Represents shares sold pursuant to a 10b5-1 plan dated August 23, 2024.

Documents

1 file

4
form4-09042025_040901.xmlPrimary

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1

filerCIK 0001468316

Filing Metadata

Form type: 4
Filed: Sep 3, 8:00 PM ET
Accepted: Sep 4, 4:10 PM ET
Size: 5.0 KB

View on SEC.gov